SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Take the Money and Run
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: X Y Zebra who wrote (5785)6/26/2002 11:59:09 AM
From: SusieQ1065  Read Replies (2) of 17639
 
11:00 ET BGEN Biogen: positive new data for Avonex (40.31 +0.14)
A press release out of the 12th annual meeting of the European Neurological Society held in Berlin says new data shows that early treatment with BGEN's multiple sclerosis drug Avonex can significantly reduce the rate at which individuals at particularly high risk for the disease actually develop clinically definite multiple sclerosis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News